SEVERE WX : Frost Advisory View Alerts

First generic EpiPen gets FDA approval

The US Food and Drug Administration has ...

Posted: Aug 17, 2018 9:38 AM
Updated: Aug 17, 2018 9:38 AM

The US Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children.

The company Teva Pharmaceuticals gained approval to market the new generic drug, according to an announcement from the FDA on Thursday.

Allergies

Business and industry sectors

Business, economy and trade

Companies

Diseases and disorders

Government organizations - US

Health and medical

Mylan

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Immunology

Medical fields and specialties

Drug safety, efficacy and availability

Drug shortages

Brendan O'Grady, executive vice president who heads North America Commercial at Teva, noted in an emailed statement Thursday that the approval "marks an important step forward in bringing our patients additional prescription medications that have met the FDA's rigorous standards."

"We're applying our full resources to this important launch in the coming months and eager to begin supplying the market," the statement said.

No details are available regarding the cost of the new generic or precisely when it will be available.

'A lower-cost option'

The approval of the generic drug comes after EpiPens were added to the FDA's drug shortage list in May and two years after the maker of EpiPen, pharmaceutical company Mylan, increased costs of its product by more than 400%, leading to public outrage.

The newly approved generic offers an alternative for patients who, until now, have been able to use only the brand-name EpiPen.

"Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval," FDA Commissioner Dr. Scott Gottlieb said in the announcement.

"This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages," he said.

EpiPen is an auto-injector that delivers epinephrine, more commonly known as adrenaline, a hormone that can help relax muscles in the airways and tighten blood vessels. It can open the airways and reduce swelling during a severe allergic reaction.

Epinephrine injection is used along with emergency medical treatment for life-threatening reactions caused by allergies to insect bites or stings, foods, medications, latex or other causes.

Yet "the path to developing generic drug-device combination products like this one is challenging," Gottlieb said, because combination drugs consist of two parts: the drug, such as epinephrine, and the device, such as the auto-injector.

"We remain committed to doing our part to provide scientific and regulatory clarity for sponsors seeking to develop complex generics, as well as prioritize the approval of medicines with little or no generic competition," Gottlieb said.

This effort is part of the administration's overarching aim to "remove barriers to generic development," as outlined in its Drug Competition Action Plan, announced last year.

"We're especially committed to the development of generic copies of complex products," Gottlieb said. "These products can be hard to copy, and therefore sometimes don't face timely generic competition once patents and exclusivities are no longer a block to approval."

He added that "we're advancing new guidance for sponsors to make the development of generic versions of complex products more efficient, and we're prioritizing review of many complex generic drug applications."

What this means for back-to-school planning

Before the new generic, the only other FDA-approved alternatives to EpiPen were the brand products Auvi-Q and Adrenaclick. The newly approved option made by Teva is the only approved non-brand option.

The American Academy of Allergy, Asthma, and Immunology is "very pleased" with the approval of the new generic, said Dr. Robert Wood, president of the academy and director of pediatric allergy and immunology at Johns Hopkins Medicine in Baltimore.

"Any measures that can improve the availability and costs of these medications is a real benefit for our patients," Wood said.

"There have been recent concerns about shortages of EpiPens, which has been especially an issue as families are refilling prescriptions for back-to-school planning," he said. "We strongly support any measures than can help provide these lifesaving medications in a more cost-effective manner, especially given the concerns about the shortages of EpiPens."

Minnesota Coronavirus Cases

Data is updated nightly.

Cases: 584227

Reported Deaths: 7297
CountyCasesDeaths
Hennepin1211481718
Ramsey50494868
Dakota45177443
Anoka40908433
Washington26429279
Stearns21950221
St. Louis17568302
Scott17036124
Wright15771136
Olmsted1312197
Sherburne1144384
Carver1035045
Clay809292
Rice7964106
Blue Earth740941
Crow Wing654188
Kandiyohi648282
Chisago584051
Otter Tail568978
Benton561497
Goodhue471972
Mower461432
Douglas460474
Winona448950
Itasca421153
McLeod417758
Morrison414560
Isanti410762
Nobles406748
Beltrami388558
Steele382015
Polk380368
Becker376450
Lyon357850
Carlton340953
Freeborn339929
Pine324121
Nicollet321443
Brown303540
Mille Lacs298252
Le Sueur286422
Todd278731
Cass266328
Meeker251340
Waseca235822
Martin228831
Roseau206119
Wabasha20383
Hubbard184241
Dodge18193
Renville178243
Redwood171536
Houston170215
Cottonwood163121
Fillmore154110
Wadena153621
Pennington153319
Chippewa151338
Faribault150319
Kanabec143024
Sibley141310
Aitkin133236
Watonwan13049
Rock127319
Jackson121411
Pipestone114226
Yellow Medicine113620
Pope10846
Murray10579
Swift104218
Stevens89211
Marshall87617
Clearwater85816
Koochiching81615
Lake80619
Wilkin79912
Lac qui Parle75022
Big Stone5934
Lincoln5733
Grant5648
Mahnomen5418
Norman5379
Unassigned49793
Kittson48222
Red Lake3957
Traverse3685
Lake of the Woods3193
Cook1560

Iowa Coronavirus Cases

Data is updated nightly.

Cases: 364967

Reported Deaths: 5920
CountyCasesDeaths
Polk57277621
Linn20729334
Scott19808240
Black Hawk15757308
Woodbury15091228
Johnson1441183
Dubuque13326209
Dallas1111198
Pottawattamie11043168
Story1054948
Warren573688
Clinton552092
Cerro Gordo536389
Sioux512874
Webster510993
Marshall481075
Muscatine474699
Des Moines451766
Wapello4284122
Buena Vista424040
Jasper413771
Plymouth400179
Lee373155
Marion360575
Jones296957
Henry290737
Carroll284752
Bremer282860
Crawford265840
Boone262734
Benton255055
Washington253350
Dickinson247543
Mahaska229351
Jackson220942
Kossuth215164
Clay214725
Tama208971
Delaware208240
Winneshiek196733
Page192222
Buchanan190431
Cedar188923
Fayette184741
Hardin184643
Wright183436
Hamilton179249
Harrison179273
Clayton169156
Butler164234
Mills161422
Madison160419
Floyd159642
Cherokee158538
Lyon157541
Poweshiek154733
Allamakee150351
Iowa148124
Hancock146834
Winnebago141231
Cass137554
Calhoun136613
Grundy136033
Emmet133940
Jefferson132135
Shelby130437
Sac130119
Appanoose128048
Louisa127849
Union127832
Mitchell125742
Chickasaw123815
Guthrie120829
Humboldt118826
Franklin117421
Palo Alto112223
Howard104122
Montgomery102838
Unassigned10080
Clarke99824
Keokuk95331
Monroe95129
Ida90234
Adair86232
Pocahontas85422
Monona82730
Davis81824
Osceola77916
Greene77610
Lucas76823
Worth7368
Taylor65612
Fremont6229
Decatur6069
Van Buren55718
Ringgold55524
Wayne53223
Audubon50610
Adams3384
Rochester
Clear
54° wxIcon
Hi: 56° Lo: 38°
Feels Like: 54°
Mason City
Clear
58° wxIcon
Hi: 61° Lo: 40°
Feels Like: 58°
Albert Lea
Partly Cloudy
55° wxIcon
Hi: 59° Lo: 39°
Feels Like: 55°
Austin
Partly Cloudy
54° wxIcon
Hi: 58° Lo: 39°
Feels Like: 54°
Charles City
Clear
° wxIcon
Hi: 60° Lo: 40°
Feels Like: °
Rain chances over the weekend
KIMT Radar
KIMT Eye in the sky

Community Events